Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor and Sargramostim for Stem Cell Mobilization in Donors
NCT01158118Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2011
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), chronic lymphocytic leukemia (CLL), sponsored by Washington University School of Medicine. Started Apr 2011; status: completed.
02
Drugs
plerixafor
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01158118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01158118.